Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor Efficacy
Suman Mukhopadhyay, Hsin‐Yi Huang, Ziyan Lin, et al.
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4095-4111
Open Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

Targeting KRAS in cancer
Anupriya Singhal, Bob T. Li, Eileen M. O’Reilly
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 969-983
Closed Access | Times Cited: 67
Determining the ERK-regulated phosphoproteome driving KRAS-mutant cancer
Jennifer E. Klomp, J. Nathaniel Diehl, Jeffrey A. Klomp, et al.
Science (2024) Vol. 384, Iss. 6700
Open Access | Times Cited: 20
The Role of KRAS Mutations in Colorectal Cancer: Biological Insights, Clinical Implications, and Future Therapeutic Perspectives
Mitsunobu Takeda, Shoma Yoshida, Takuya Inoue, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 428-428
Open Access | Times Cited: 2
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors
A. Cole Edwards, Clint A. Stalnecker, Alexis Jean Morales, et al.
Cancer Research (2023) Vol. 83, Iss. 24, pp. 4112-4129
Open Access | Times Cited: 30
The Extracellular Niche and Tumor Microenvironment Enhance KRAS Inhibitor Efficacy in Pancreatic Cancer
Vishnu Kumarasamy, Jianxin Wang, Costakis Frangou, et al.
Cancer Research (2024) Vol. 84, Iss. 7, pp. 1115-1132
Open Access | Times Cited: 14
Hippo Signaling at the Hallmarks of Cancer and Drug Resistance
Ramesh Kumar, Wanjin Hong
Cells (2024) Vol. 13, Iss. 7, pp. 564-564
Open Access | Times Cited: 12
Dynamic Multilevel Regulation of EGFR, KRAS, and MYC Oncogenes: Driving Cancer Cell Proliferation Through (Epi)Genetic and Post-Transcriptional/Translational Pathways
Mário Šereš, Katarina Spacayova, Zdena Sulová, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 248-248
Open Access | Times Cited: 1
Emerging Targeted Therapies in Non-Small-Cell Lung Cancer (NSCLC)
Syeda A. Mina, Mohamed Shanshal, Konstantinos Leventakos, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 353-353
Open Access | Times Cited: 1
The ANGPTL4-HIF-1α loop: a critical regulator of renal interstitial fibrosis
Yan Li, Shuang Chen, Qian Yang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
KRAS inhibitors: resistance drivers and combinatorial strategies
Tamara Isermann, Christine Sers, Channing J. Der, et al.
Trends in cancer (2024)
Open Access | Times Cited: 6
MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
Olaf Klingbeil, Damianos Skopelitis, Claudia Tonelli, et al.
Cancer Discovery (2024) Vol. 14, Iss. 12, pp. 2471-2488
Open Access | Times Cited: 5
Decoding driver and phenotypic genes in cancer: Unveiling the essence behind the phenomenon
Dequan Liu, Lei Liu, Xiaoman Zhang, et al.
Molecular Aspects of Medicine (2025) Vol. 103, pp. 101358-101358
Open Access
Navigating Glioma Complexity: The Role of Abnormal Signaling Pathways in Shaping Future Therapies
Qiang Chen, Jin Jin, Pian Li, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 759-759
Open Access
CAR T-Cell Therapy in Chronic Myeloid Leukemia Patients with Lymphoid Blast Crisis: A Multicenter Clinical Analysis
Yujie Liu, Yuqing Tu, Zhiling Yan, et al.
Cancer Letters (2025), pp. 217688-217688
Closed Access
Combination Therapy Approach to Overcome the Resistance to PI3K Pathway Inhibitors in Gynecological Cancers
Kristen R. Ibanez, Tzu‐Ting Huang, Jungmin Lee
Cells (2024) Vol. 13, Iss. 12, pp. 1064-1064
Open Access | Times Cited: 4
Amplification of Hippo Signaling Pathway Genes Is Governed and Implicated in the Serous Subtype-Specific Ovarian Carcino-Genesis
Karthik Balakrishnan, Yuanhong Chen, Jixin Dong
Cancers (2024) Vol. 16, Iss. 9, pp. 1781-1781
Open Access | Times Cited: 3
p53 Genetics and Biology in Lung Carcinomas: Insights, Implications and Clinical Applications
Dixan A. Benitez, Guadalupe Cumplido-Laso, Marcos Olivera-Gómez, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1453-1453
Open Access | Times Cited: 2
Exploring Predictive and Prognostic Biomarkers in Colorectal Cancer: A Comprehensive Review
Karam Ashouri, Alexandra C. Wong, Pooja Mittal, et al.
Cancers (2024) Vol. 16, Iss. 16, pp. 2796-2796
Open Access | Times Cited: 2
Harnessing Tumor Mechanobiology in NSCLC Treatment
Kostas A. Papavassiliou, Vassiliki A. Gogou, Athanasios G. Papavassiliou
Archivos de Bronconeumología (2024) Vol. 60, Iss. 8, pp. 523-525
Closed Access | Times Cited: 1
The Target Therapy Hyperbole: “KRAS (p.G12C)”—The Simplification of a Complex Biological Problem
Massimiliano Chetta, Anna Basile, Marina Tarsitano, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2389-2389
Open Access | Times Cited: 1
An improved TEAD dominant-negative protein inhibitor to study Hippo YAP1/TAZ-dependent transcription.
Briana Branch, Yao Yuan, Mariastella Cascone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Clinical Advances and Challenges in Targeting KRAS Mutations in Non-Small Cell Lung Cancer
Simone E. Dekker, Lei Deng
Cancers (2024) Vol. 16, Iss. 22, pp. 3885-3885
Open Access | Times Cited: 1
Gastric Adenocarcinomas with CDX2 Induction Show Higher Frequency of TP53 and KMT2B Mutations and MYC Amplifications but Similar Survival Compared with Cancers with No CDX2 Induction
Ioannis A. Voutsadakis
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7635-7635
Open Access | Times Cited: 1
Ferredoxin 1: a gatekeeper in halting lung adenocarcinoma progression through activation of the GPRIN2 signaling pathway
Ming Liu, Shaoxian Wu, Haoyu Wu, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
S100A6 Regulates nucleus pulposus cell apoptosis via Wnt/β-catenin signaling pathway: an in vitro and in vivo study
Fengguang Yang, Yanni Duan, Yanhu Li, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top